General Information of the Compound
Compound ID |
CP0077167
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]proline;hydrate
Show/Hide
|
||||||||||||||||||
Synonyms |
Acerbon
Acercomp
Alapril
Carace
Cipral
Cipril
Coric
Doneka
Hipril (TN)
Inhibril
Inopril
LPR
Linopril
Linvas
Lipril
Lisinal
Lisinopril
Lisinopril (INN)
Lisinopril (anhydrous)
Lisinopril anhydrous
Lisinoprilum
Lisinoprilum [Latin]
Lisipril
Lisoril
Lispril
Longes
Loril
Lysinopril
MK 521
MK 522
MK-521
Noperten
Novatec
Presiten
Prinil
Prinivil
Prinivil (TN)
Sinopril
Sinopryl
Tensopril
Tensopril (TN)
Tensyn
Tersif
Vivatec
Zestril
Zestril (TN)
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C21H31N3O5
|
||||||||||||||||||
Molecular Weight |
405.495
|
||||||||||||||||||
Canonical SMILES |
NCCCC[C@H](N[C@@H](CCc1ccccc1)C(O)=O)C(=O)N1CCC[C@H]1C(O)=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C21H31N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29)/t16-,17-,18-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
RLAWWYSOJDYHDC-BZSNNMDCSA-N
|
||||||||||||||||||
CAS |
77726-95-5
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00932, Angiotensin-converting enzyme
Clinical Information about the Compound
Drug 1 ( Lisinopril )
Drug Name | Lisinopril | ||
---|---|---|---|
Company | Merck & Co | ||
Indication | |||
Target(s) |